Imunon, Inc.
IMNN
$1.16
$0.7445179.18%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | 123.02% | -385.64% | |||
| Gross Profit | -123.02% | 385.64% | |||
| SG&A Expenses | 3.49% | 14.70% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -0.02% | -16.43% | |||
| Operating Income | 0.02% | 16.43% | |||
| Income Before Tax | -1.12% | 16.27% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -1.12% | 16.27% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -1.12% | 16.27% | |||
| EBIT | 0.02% | 16.43% | |||
| EBITDA | 0.74% | 16.10% | |||
| EPS Basic | -0.86% | 16.70% | |||
| Normalized Basic EPS | -0.86% | 16.70% | |||
| EPS Diluted | -0.86% | 16.70% | |||
| Normalized Diluted EPS | -0.86% | 16.70% | |||
| Average Basic Shares Outstanding | 0.25% | 0.54% | |||
| Average Diluted Shares Outstanding | 0.25% | 0.54% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||